Assenagon Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $698K | Buy |
+17,654
| New | +$698K | ﹤0.01% | 958 |
|
|
2025
Q1 | – | Sell |
-141,917
| Closed | -$4.96M | – | 1232 |
|
|
2024
Q4 | $4.96M | Buy |
141,917
+128,619
| +967% | +$4.5M | 0.01% | 663 |
|
|
2024
Q3 | $533K | Sell |
13,298
-10,928
| -45% | -$438K | ﹤0.01% | 1199 |
|
|
2024
Q2 | $1.15M | Sell |
24,226
-247,037
| -91% | -$11.8M | ﹤0.01% | 1038 |
|
|
2024
Q1 | $11.8M | Buy |
271,263
+86,862
| +47% | +$3.77M | 0.03% | 363 |
|
|
2023
Q4 | $9.33M | Buy |
+184,401
| New | +$9.33M | 0.02% | 443 |
|
|
2023
Q2 | – | Sell |
-27,185
| Closed | -$972K | – | 1342 |
|
|
2023
Q1 | $972K | Sell |
27,185
-414,617
| -94% | -$14.8M | ﹤0.01% | 1026 |
|
|
2022
Q4 | $16.7M | Sell |
441,802
-10,958
| -2% | -$414K | 0.06% | 253 |
|
|
2022
Q3 | $20M | Buy |
452,760
+112,044
| +33% | +$4.96M | 0.08% | 223 |
|
|
2022
Q2 | $12.6M | Sell |
340,716
-17,180
| -5% | -$636K | 0.05% | 296 |
|
|
2022
Q1 | $13.3M | Buy |
357,896
+309,495
| +639% | +$11.5M | 0.04% | 282 |
|
|
2021
Q4 | $1.47M | Buy |
48,401
+42,379
| +704% | +$1.29M | ﹤0.01% | 901 |
|
|
2021
Q3 | $202K | Buy |
+6,022
| New | +$202K | ﹤0.01% | 1194 |
|
|
2020
Q4 | – | Sell |
-36,475
| Closed | -$1.73M | – | 1086 |
|
|
2020
Q3 | $1.73M | Buy |
36,475
+32,727
| +873% | +$1.55M | 0.01% | 589 |
|
|
2020
Q2 | $221K | Buy |
+3,748
| New | +$221K | ﹤0.01% | 1027 |
|